Medische hulpmiddelen en geneesmiddelen: Verschuivende grenzen in Brussel?



Similar documents
The information contained in these slides is for general purposes only and presents the state of knowledge at November 30, 2011

CE Marking Changing & Evolving Requirements September BSI Healthcare Roadshow

Update: Proposed Medical Device Regulation (MDR) & IVD Regulation (IVDR)

Informatiebeveiliging volgens ISO/IEC 27001:2013

TRANSATLANTIC TRADE AND INVESTMENT PARTNERSHIP

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL

Brief Summary on the Philippine B bilateral Air Services Agreement

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL VERSION 4.1

A COMPARATIVE TABLE OF THE CURRENT EC AND EU TREATIES AS AMENDED BY THE TREATY OF LISBON

No. prev. doc.: 9392/08 SAN 77 DENLEG 48 VETER 5 Subject: EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS COUNCIL MEETING ON 9 AND 10 JUNE 2008

Software within the medical device regulatory framework in the EU

A Comparative Case Study on the Relationship between EU Unity and its Effectiveness in Multilateral Negotiations

TELECOM SOCIETY 2 JULI Over de moeizame verhouding tussen de privacywet en big data. En wat we daaraan kunnen doen. prof mr.

Official Journal of the European Union. (Acts whose publication is obligatory)

Authorisation and Restriction Newsletter

Medical Devices: CE Marking Step-by Step

Assuring the Cloud. Hans Bootsma Deloitte Risk Services +31 (0)

8485/15 SC/GDLC/io 1 DGB 1

COMMISSION RECOMMENDATION. of XXX

EPF Position Statement on the European Commission s proposal for a Regulation on In Vitro Medical Devices

CLP regulation & 2015 deadline for mixtures

Emerging Device Topics for Regulatory Consideration.. Janine Jamieson May 2015

SAFETY DATA SHEET EVO-STIK PLUMBERS MAIT

COMMISSION OF THE EUROPEAN COMMUNITIES GREEN PAPER

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL

COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL. Proposal for an Interinstitutional Agreement on Better Regulation

Handling impact assessments in Council

REGULATION (EEC) No 2309/93

TRACTATENBLAD VAN HET KONINKRIJK DER NEDERLANDEN. JAARGANG 2015 Nr. 93

EUROPEAN COMMISSION Employment, Social Affairs and Equal Opportunities DG COMMUNITY PROGRAMME FOR EMPLOYMENT AND SOCIAL SOLIDARITY (PROGRESS)

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY VERSION 7

2. Europol's cooperation agreements with third countries and international organisations (Art. 31);

GUIDANCE NOTES FOR MANUFACTURERS OF CLASS I MEDICAL DEVICES

1. Product and Company Identification

HSE: Frequently Asked Questions

Strong support. Remaining concerns

ISACA Roundtable. Cobit and 7 september 2015

UEMS 2004 / 47 EN ADOPT ED

Behavioral Targeting Legal Developments in Europe and the Netherlands

COMMISSION DECISION. of establishing the REFIT Platform

Kansen in KP7 NMP. Aansluitend op de HTSM Roadmap Nanotechnologie. 11 juni Melvin A. Kasanrokijat

SAFETY DATA SHEET BOSTIK AQUAGRIP 536

RECOMMENDATION 2013/473/EU ON NOTIFIED BODIES AUDITS

002475/EU XXV. GP. Eingelangt am 18/11/13 COUNCIL OF THE EUROPEAN UNION. Brussels, 18 November 2013 (OR. en)

HIPPO STUDY DG Education And Culture Study On The Cooperation Between HEIs And Public And Private Organisations In Europe. Valorisatie 9/26/2013

Authorisation and Restriction: Interplay and other Strategic Considerations

GMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP)

GUIDANCE DOCUMENT No. 10 ON THE APPLICATION OF THE DIRECTIVE ON THE SAFETY OF TOYS MUSIC INSTRUMENTS

DISCUSSION NON-PAPER. How to put ideas for cooperation under TTIP into practice a few examples

002400/EU XXV. GP. Eingelangt am 18/11/13. Brussels, 16 November 2013 COUNCIL OF THE EUROPEAN UNION 16030/1/13 REV 1

Offshore Wind in Germany

12040/1/15 REV 1 LES/ns 1 DG B 3B

Changes to Medical Device Regulations

16525/1/12 REV 1 GS/np 1 DG D 2B

Regulatory Strategy for Drug-Device Combinations By John Worroll

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice

RULES OF THE TENNESSEE DEPARTMENT OF INTELLECTUAL AND DEVELOPMENTAL DISABILITIES

Section 1: Development of the EU s competence in the field of police and judicial cooperation in criminal matters

Evaluation reports from the Commission on Reimbursement of Medicines (CRM) and the Medical Pharmaceutical Committee (MFC) as specific target group

COMMISSION REGULATION (EU) No. of XXX

Pharmacy Technician Training Program. Minimum Competencies

EBA/RTS/2016/ January Final Report

The EBA s competence to deliver an opinion is based on the sixth subparagraph of Article 10(1) of Regulation (EU) No 1093/

Dutch Mortgage Market Pricing On the NMa report. Marco Haan University of Groningen November 18, 2011

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a RECOMMENDATION OF THE COUNCIL AND OF THE EUROPEAN PARLIAMENT

COUNCIL OF THE EUROPEAN UNION. Brussels, 29 September /09 LIMITE PI 93

BUBBLE JUICE CC AMERICAN DJ

Working together for healthier living

Drafted by ENTSOE. NCs impact DSOs grid ooperation. Approved at EU level. Network Codes. Significant Costs for EU DSOs - billions

Georgios Katsarakis Europäische Kommission

SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING. Enzymatic Drain Cleaner and Maintainer

TERMS OF REFERENCE Electronic Communications Resilience and Response Group (EC RRG)

COMMISSION OF THE EUROPEAN COMMUNITIES

EMA Update Clinical Trials

Lean Maintenance & Asset Management The Best of Both Worlds

COMMISSION RECOMMENDATION. of XXX. on the right to legal aid for suspects or accused persons in criminal proceedings

16094/14 MM/mj 1 DG E - 1C

Reporting Changes to your Notified Body

IP-NBM. Copyright Capgemini All Rights Reserved

Samenwerken in/aan een green deal Opties voor CO2 reductie op en rondom het spoor

Resources Based, Manufacturing and Consumer Goods Industries Chemicals Industry

Tooth Whitening/Dental Bleaching Products Containing Hydrogen Peroxide in the European Union

Importing pharmaceutical products to China

European Council Brussels, 2 February 2016 (OR. en)

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL

UK Indirect Tax Conference 2015 How does the EU do VAT? Aili Nurk 11 November 2015

Transcription:

Medische hulpmiddelen en geneesmiddelen: Verschuivende grenzen in Brussel? Sabina Hoekstra-van den Bosch Philips HealthTech, Global Regulations & Standards Arnhem, June 19, 2015

Samenvatting Verschil tussen geneesmiddel en medisch hulpmiddel (herhaling) Nieuw mechanisme voor statusbepaling van medische hulpmiddelen op Europees niveau Substance based medical devices 2 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

Fundamental difference between medical device and pharmaceutical 4 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

Simplified EU definition of a medical device Any product Intended for a medical purpose For humans Which does not act by pharmacological, immunological or metabolic means Fundamental difference with pharmaceutical products is mechanism of action 5 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

Statusbepaling van medische hulpmiddelen op Europees niveau 4 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

Statusbepaling medische hulpmiddelen in EU Huidige situatie Majority of cases: no doubt! In case of doubt: No seamless coherence between the definitions of medicinal products and medical device Decisive power lies with national judges Possibility to appeal to EU Court of Justice Demarcation procedure between pharmaceuticals and medical devices can be quite complicated! 4 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

Nieuw mechanisme voor statusbepaling? EU COM proposal MDR + Council changes 3 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

Wat betekent dit??? Sleutelwoorden/begrippen Art 2.2 of Directive 2001/83 Implementing acts MDCG 5 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

Medicinal Product Directive 2001/83, art 2.2 In cases of doubt, where, taking into account all its characteristics, a product may fall within the definition of a medicinal product and within the definition of a product covered by other Community legislation the provisions of this Directive shall apply. 4 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

Comitology Legislative process light System gradually developed from the 60-ties For implementing measures only Drafted by EU COM Voted upon by Council (Member States) by QMV European Parliament asked for the equal rights as co-legislator 2006: Veto right for European Parliament 10 1

Treaty of Lisbon (2010) Fundamental changes to comitology procedures, now called implementing acts Creation of a new legal instrument for delegation to EU Commission: delegated acts. Equality between EP and Council in limited control over both delegated and implementing acts (veto-right) And the winner is.. 11 1

Medical Device Coordination Group (MDCG) Commission proposal MDR art 80 Consisting of representatives of Member States (1 for MDs, 1 for IVDs, with an alternate for each) Members chosen for their competence and experience Members must be impartial Chaired and supported (logistically, technically and scientifically) by EU Commission Experts of other stakeholders (medical device industry, healthcare professionals, laboratories, patients and consumers) may be invited in subgroups as observer on case-by-case basis 12 1

Wat betekent dit als Medical Device Regulation van kracht is? Regulation (=Verordening) rechtstreeks van toepassing in alle lidstaten Statusbepaling dmv Implementing acts met Europese Commissie aan het roer MDCG (lidstaten) worden tevoren geraadpleegd Beroep tegen Implementing act ingewikkeld (voor gevorderde Europees juristen.) 5 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

substance based medical devices 13 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

substance based medical devices Background Increasing number of ingested or absorbed products with medical claims Not possible to demonstrate that (some of) these products have any pharmacological, immunological or metabolic action/effect Historically a lot of these products have been placed on the market as medicinal products Identical products regulated as medicinal products, medical devices or food supplements. Differences in interpretation between Member States, but also within Member States. When the Medical Device Directive was drafted (mid-eighties), legislators did not intend to cover products which are ingested or absorbed, so some adaptation might be needed in order to cover these products properly. Examples: some nasal sprays, gels for vaginal discomfort, throat lozenges, toothpastes for sensitive teeth, flushing solutions, creams to treat or prevent minor skin irritations, comfort eye drops or anti-flatulence products 15 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

substance based medical devices Solution: substance based medical devices defined in MDR: Adaptation of Classification rules General Safety and Performance Requirements Conformity Assessment Procedures Labelling and Instructions for use Referral to relevant provisions in 2001/83 Provoked lots of intense discussion, e.g. on Definition Risk classification 15 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

Definition of substance based medical devices EU COM proposal MDR + Council changes Devices that are composed of substances or combinations of substances that are intended to be ingested inhaled or administered rectally or vaginally introduced into the human body via a body orifice, or applied on skin and that are absorbed by or locally dispersed in the human body 16 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

Classification of substance based medical devices (Annex VII) 19 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

General Safety and Performance Requirements MDR Annex I 14 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

Labelling MDR Annex I, 19.2 15 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

Instructions for use MDR Annex I, 19.3 16 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

Technical documentation Annex II.6.2 17 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

Dank voor uw aandacht! 24 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards